|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CLRB
|
Cellectar Biosciences, Inc.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
US
|
NASDAQ
|
|
DRTS
|
Alpha Tau Medical Ltd.
|
US
|
NASDAQ
|
|
EBS
|
Emergent Biosolutions, Inc.
|
US
|
NYSE
|
|
ENLV
|
Enlivex Therapeutics Ltd.
|
US
|
NASDAQ
|
|
ENOB
|
Enochian Biosciences, Inc.
|
US
|
NASDAQ
|
|
FUSN
|
Fusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
GRCL
|
Gracell Biotechnologies Inc.
|
US
|
NASDAQ
|
|
GTBP
|
GT Biopharma, Inc.
|
US
|
NASDAQ
|